InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,214.08
(
0.51%
)
US TECH 100
17,713.60
(
0.41%
)
Dow Jones
39,387.76
(
0.00%
)
Brent Oil
84.08
(
0.15%
)
Bitcoin
63,307.69
(
0.41%
)
Post# of 130502
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

JJAAMMAANN

Send PM Follow Ignore
Followers 29
Posts 940
Boards Moderated 0
Alias Born 03/10/2014

JJAAMMAANN

Re: SidVicious post# 115002

Monday, 06/08/2015 8:43:24 AM

Monday, June 08, 2015 8:43:24 AM

Post# of 130502
Not aware of any announcements regarding numbers, other than what was approved by the FDA for the Phase 2B. Eltoprazine has already been tested in more than 800 persons, so the FDA knows it is safe in humans. This trial is specifically focused on its effectiveness of treating LID.

In My Own Personal Opinion Of Course!
Long ANAS!

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
InvestorsHub NewsWire

Avant Technologies Equipping AI-Managed Data Center with High Performance Computing Systems • AVAI • May 10, 2024 8:00 AM

VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM

Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM

Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM

Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM

Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM

Start posting your company's news
Only $200 per official company press release!